GeneOne Life Science Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	5,298	1,319	1,180	9,111	13,261	22,310
Short-Term Investments	194.8	184.7	566.19	406.6	32,342	85,094
Trading Asset Securities	231.18	231.18	-	470.79	-	-
Cash & Short-Term Investments	5,724	1,735	1,746	9,988	45,603	107,404
Cash Growth	45.12%	-0.67%	-82.52%	-78.10%	-57.54%	18.65%
Accounts Receivable	1,978	1,742	7,182	6,624	8,980	7,438
Other Receivables	715.92	349.04	1,050	948.44	1,598	1,975
Receivables	3,793	2,663	8,310	7,652	10,659	10,091
Inventory	13,121	13,422	16,511	14,897	14,864	10,688
Prepaid Expenses	855.78	629.02	1,542	1,225	1,145	706.46
Other Current Assets	1,176	988.11	525.52	811	793.08	5,744
Total Current Assets	24,670	19,437	28,635	34,573	73,063	134,633
Property, Plant & Equipment	102,054	95,400	117,730	111,399	144,369	110,382
Long-Term Investments	16.15	15.31	18.5	50.39	147.49	437.33
Other Intangible Assets	218.14	208.41	189.96	385.99	563.91	643.1
Long-Term Deferred Tax Assets	109.08	103.42	21.71	13.28	36.42	14.24
Other Long-Term Assets	4,221	4,043	4,739	4,586	4,687	4,735
Total Assets	131,287	119,207	151,334	151,008	222,867	250,857
Accounts Payable	26,325	24,641	20,176	10,066	7,493	17,531
Accrued Expenses	1,883	3,820	4,910	1,971	2,327	1,173
Short-Term Debt	9,390	9,201	3,377	2,405	12,246	9,754
Current Portion of Leases	1,259	1,472	2,895	2,396	1,911	1,543
Other Current Liabilities	15,065	14,671	11,147	6,029	9,858	4,758
Total Current Liabilities	53,922	53,806	42,506	22,867	33,836	34,759
Long-Term Debt	21,113	20,018	16,373	6,273	-	-
Long-Term Leases	2,390	2,266	4,480	6,085	5,509	7,103
Pension & Post-Retirement Benefits	139.43	122.12	24.1	2,096	-	820.35
Long-Term Deferred Tax Liabilities	30.9	29.3	154.83	323.98	457.33	144.32
Other Long-Term Liabilities	2,537	2,068	2,192	1,872	1,594	1,524
Total Liabilities	80,132	78,309	65,729	39,518	41,395	44,350
Common Stock	90,883	85,410	80,039	78,474	77,752	77,479
Additional Paid-In Capital	225,771	223,175	217,579	215,555	214,299	209,871
Retained Earnings	-319,218	-316,836	-264,848	-216,231	-137,155	-98,241
Treasury Stock	-2,955	-2,955	-2,955	-2,955	-2,955	-2,955
Comprehensive Income & Other	56,675	52,104	55,791	36,647	29,531	20,353
Shareholders' Equity	51,155	40,898	85,605	111,489	181,471	206,507
Total Liabilities & Equity	131,287	119,207	151,334	151,008	222,867	250,857
Total Debt	34,152	32,958	27,126	17,160	19,666	18,400
Net Cash (Debt)	-28,428	-31,223	-25,379	-7,171	25,937	89,004
Net Cash Growth	-	-	-	-	-70.86%	22.34%
Net Cash Per Share	-335.94	-378.60	-319.49	-92.24	334.73	1198.84
Filing Date Shares Outstanding	88.22	85.2	79.83	78.26	77.54	77.27
Total Common Shares Outstanding	88.22	85.2	79.83	78.26	77.54	77.27
Working Capital	-29,253	-34,369	-13,870	11,705	39,227	99,875
Book Value Per Share	579.84	480.02	1072.35	1424.52	2340.29	2672.55
Tangible Book Value	50,937	40,690	85,415	111,103	180,907	205,864
Tangible Book Value Per Share	577.37	477.58	1069.97	1419.59	2333.02	2664.23
Land	3,860	3,607	3,720	3,139	4,081	3,817
Buildings	79,145	74,505	76,192	63,374	1,403	1,331
Machinery	57,509	56,904	55,318	48,599	15,199	11,775
Construction In Progress	-	-	-	-	104,661	78,283
Leasehold Improvements	17,468	17,230	16,414	14,867	13,139	12,124

Source: S&P Global Market Intelligence. Standard template. Financial Sources.